Verbatim response from ChatGPT
Short answer: there’s no single “FDA seal” that proves a compounded product is FDA‑approved — FDA generally does not approve compounded drugs. Instead, you check whether the pharmacy follows the right laws and third‑party standards. For semaglutide (a peptide that must be sterile when injected) this matters a lot.
What to check (step‑by‑step)
-
Is the pharmacy licensed by the state board of pharmacy?
- Find and verify the pharmacy’s license on the state board of pharmacy website (or ask the board by phone). A legitimate U.S. pharmacy will give its state license number; confirm it.
-
Is it a 503B outsourcing facility registered with the FDA?
- Outsourcing facilities that compound sterile drugs can voluntarily register with FDA and are inspected to current GMP standards. Search the FDA’s list of registered 503B outsourcing facilities to see if the company is listed.
-
Does it require a valid prescription and provide pharmacist access?
- Legit pharmacies will require a patient‑specific prescription for compounding OR clearly explain their 503B status for non‑patient‑specific batches. They should provide a licensed pharmacist’s contact info and a physical business address and phone number.
-
Look for independent accreditation
- Recognized third‑party accreditations add assurance: e.g., NABP/VIPPS (NABP’s online pharmacy verification), ACHC compounding accreditation, or other well‑known accreditors. Ask which accreditations they hold, then verify with the accreditor.
-
Ask for Certificates of Analysis (COAs) and testing
- For peptides and injectable compounds, request batch COAs showing identity, potency, sterility and endotoxin testing performed by an independent lab. Reputable compounding operations will provide them on request.
-
Check FDA & state records for warnings or inspection problems
- Search FDA Warning Letters and the FDA’s inspection/recall pages for the pharmacy or outsourcing facility name. Also ask your state board if there are complaints on file.
-
Check provenance and handling
- Semaglutide is temperature‑sensitive and requires sterile compounding and appropriate cold chain shipping. Confirm how they source the active ingredient (from FDA‑approved/traceable suppliers), how they compound (sterile cleanrooms), and how they ship (refrigerated overnight with tracking).
Red flags (don’t use if you see these)
- No prescription required.
- No pharmacist contact, no physical address, or overseas-only address.
- Prices that are dramatically lower than expected.
- No batch COAs or refusal to explain testing/sterility procedures.
- Claims of “exact copy” superiority to branded products or promises of unbelievably fast weight loss.
- Shipping from countries with weak regulation and no U.S. licensing.
Regulatory context worth knowing
- 503A compounding pharmacies (traditional) are regulated primarily by state boards and may only compound for individual patients on prescription; they aren’t FDA‑inspected to cGMP standards in the same routine way as 503B facilities.
- 503B outsourcing facilities may compound non‑patient‑specific sterile products and can register with FDA and be inspected under cGMP.
- FDA has cautioned about compounding copies of approved drugs when safe approved options exist. For many patients, using FDA‑approved semaglutide products (Wegovy, Ozempic, Rybelsus — Novo Nordisk) dispensed through a regular licensed pharmacy is the safer route.
Practical recommendation
- Prefer getting semaglutide as an FDA‑approved product (Ozempic for diabetes or Wegovy for weight loss) dispensed at a major retail pharmacy (CVS, Walgreens, Walmart, or your local independent pharmacy). If you must use a compound, only proceed after verifying state license, 503B registration (if applicable), third‑party accreditation, batch COAs, and proper cold‑chain shipping.
If you want, tell me the name and website of the pharmacy you’re considering and I’ll walk through verifiable items (license, accreditation, 503B status, red flags) for that specific vendor.